ER PROTEINS EFFECT ON CLASS I MHC ASSEMBLY
ER 蛋白对 I 类 MHC 组装的影响
基本信息
- 批准号:2910408
- 负责人:
- 金额:$ 15.32万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1998
- 资助国家:美国
- 起止时间:1998-05-01 至 2003-04-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The cellular immune system defense against viruses and tumors depends on
the presentation of peptides derived from viral or tumor-specific proteins
to T lymphocytes. These peptides must be bound by cell-surface class 1
major histocompatibility complex (MHC) heavy chains to be recognized by
lymphocytes. Assembly of the class 1 MHC heavy chains, a light chain
called beta 2-microglobulin (beta 2-m) and peptide into the
heterotrimeric, complete class I MHC molecule occurs in the endoplasmic
reticulum(ER). During class 1 assembly, ER resident proteins such as
calreticulin, the transporter associated with antigen processing (TAP),
and tapasin interact with peptide-free class 1 heavy chain/beta 2-m. The
long-term goals of this study are to understand the mechanism and
regulation of the immune response at the level of peptide loading and
assembly of the class 1 MHC molecule. The first three studies described in
this grant proposal will define the separate roles of each of these ER
proteins in the retention of class 1 prior to peptide loading and will
probe the nature of their molecular interactions with class 1.
Specifically, these studies will 1) determine the importance of class 1
heavy chain glycosylation and the alpha 3 domain for calreticulin
association with class 1, 2) define the role of calreticulin in the ER
retention of class 1 by the use of cells that over-express, under-express,
or do not express calrecticulin, and 3) determine whether TAP,
calrecticulin, or tapasin is responsible for the peptide-induced release
of class 1 from ER retention. The assembly and surface expression of the
class 1 molecule is blocked by several viral proteins. Knowledge of the
mechanisms of viral interference in class 1 assembly can reveal a great
deal about the normal processes of antigen presentation. One example of
such a viral protein is the adenovirus E3-19K protein, which is weakly
homologous to members of the immunoglobulin supergene family and so may
have an as yet undiscovered cellular homologue. Whether E3-19K displaces
peptide or any of the normal ER proteins that chaperone class 1 (calnexin,
calreticulin, TAP, or tapasin) is not known. To resolve these issues, the
final aim of this proposal is to determine whether the class 1 heavy
chains that bind to E3-19K are peptide-occupied and if they have lost
association with ER chaperones. In summary, these studies will yield new
insights into the regulation of antigen presentation and will be helpful
in the future design of rational approaches for clinical treatment of
cancer and viral diseases.
细胞免疫系统防御病毒和肿瘤依赖
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Joyce C Solheim其他文献
Joyce C Solheim的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Joyce C Solheim', 18)}}的其他基金
Ewing's Sarcoma Resistance to Immunity and Radiation
尤文氏肉瘤对免疫和辐射的抵抗力
- 批准号:
8502033 - 财政年份:2013
- 资助金额:
$ 15.32万 - 项目类别:
Ewing's Sarcoma Resistance to Immunity and Radiation
尤文氏肉瘤对免疫和辐射的抵抗力
- 批准号:
8620629 - 财政年份:2013
- 资助金额:
$ 15.32万 - 项目类别:
Effect of Beta-secretase Inhibitors on Pancreatic Cancer Cells
β-分泌酶抑制剂对胰腺癌细胞的作用
- 批准号:
8358516 - 财政年份:2012
- 资助金额:
$ 15.32万 - 项目类别:
Effect of Beta-secretase Inhibitors on Pancreatic Cancer Cells
β-分泌酶抑制剂对胰腺癌细胞的作用
- 批准号:
8508899 - 财政年份:2012
- 资助金额:
$ 15.32万 - 项目类别:
PROJECT 4:MECHANISMS FACILITATING GROWTH & METASTASIS OF PANCREATIC CANCER
项目 4:促进增长的机制
- 批准号:
8360444 - 财政年份:2011
- 资助金额:
$ 15.32万 - 项目类别:
ER Proteins Effect on Class I MHC Assembly
ER 蛋白对 I 类 MHC 组装的影响
- 批准号:
7922974 - 财政年份:2009
- 资助金额:
$ 15.32万 - 项目类别:
相似海外基金
Restoring MHC class I antigen presentation to enhance anti-tumour immunity
恢复MHC I类抗原呈递,增强抗肿瘤免疫力
- 批准号:
nhmrc : GNT1164054 - 财政年份:2020
- 资助金额:
$ 15.32万 - 项目类别:
Project Grants
Subversion of MHC class I antigen presentation by viral immunomodulatory proteins
病毒免疫调节蛋白颠覆 MHC I 类抗原呈递
- 批准号:
8996707 - 财政年份:2014
- 资助金额:
$ 15.32万 - 项目类别:
Ubiquitin conjugation and direct MHC class I antigen presentation
泛素结合和直接 MHC I 类抗原呈递
- 批准号:
8880646 - 财政年份:2014
- 资助金额:
$ 15.32万 - 项目类别:
Subversion of MHC class I antigen presentation by viral immunomodulatory proteins
病毒免疫调节蛋白颠覆 MHC I 类抗原呈递
- 批准号:
9206412 - 财政年份:2014
- 资助金额:
$ 15.32万 - 项目类别:
Subversion of MHC class I antigen presentation by viral immunomodulatory proteins
病毒免疫调节蛋白颠覆 MHC I 类抗原呈递
- 批准号:
8723605 - 财政年份:2014
- 资助金额:
$ 15.32万 - 项目类别:
MHC Class I Antigen Presentation in Viral Infections
病毒感染中 MHC I 类抗原呈递
- 批准号:
8072956 - 财政年份:2010
- 资助金额:
$ 15.32万 - 项目类别:
MHC Class I Antigen Presentation in Viral Infections
病毒感染中 MHC I 类抗原呈递
- 批准号:
7991835 - 财政年份:2001
- 资助金额:
$ 15.32万 - 项目类别:
MHC Class I Antigen Presentation in Viral Infections
病毒感染中 MHC I 类抗原呈递
- 批准号:
7329795 - 财政年份:2001
- 资助金额:
$ 15.32万 - 项目类别:
MHC Class I Antigen Presentation in Viral Infections
病毒感染中 MHC I 类抗原呈递
- 批准号:
7535232 - 财政年份:2001
- 资助金额:
$ 15.32万 - 项目类别:
MHC Class I Antigen Presentation in Viral Infections
病毒感染中 MHC I 类抗原呈递
- 批准号:
7738528 - 财政年份:2001
- 资助金额:
$ 15.32万 - 项目类别:














{{item.name}}会员




